SLU-PP-332 supplied as fixed-dose tablets. As a pan-estrogen-related receptor agonist it is studied for mitochondrial biogenesis and oxidative metabolism; the tablet format keeps dosing consistent between research sessions.
Active ingredient purity is tested (≥99.4%) and identity confirmed before formulation into tablet form.
Tablets remain stable at room temperature provided they are kept dry and away from light exposure. Available for delivery throughout Indonesia, packaged to preserve product condition.
For in-vitro and laboratory research use only.